Your browser doesn't support javascript.
loading
The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials.
de Koning, Harry J; Gulati, Roman; Moss, Sue M; Hugosson, Jonas; Pinsky, Paul F; Berg, Christine D; Auvinen, Anssi; Andriole, Gerald L; Roobol, Monique J; Crawford, E David; Nelen, Vera; Kwiatkowski, Maciej; Zappa, Marco; Luján, Marcos; Villers, Arnauld; de Carvalho, Tiago M; Feuer, Eric J; Tsodikov, Alex; Mariotto, Angela B; Heijnsdijk, Eveline A M; Etzioni, Ruth.
Afiliación
  • de Koning HJ; Department of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Gulati R; Division of Public Health Sciences, Fred Hutchinson Cancer Research Institute, Seattle, Washington.
  • Moss SM; Wolfson Institute, Queen Mary University of London, London, United Kingdom.
  • Hugosson J; Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden.
  • Pinsky PF; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.
  • Berg CD; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins Medicine, Baltimore, Maryland.
  • Auvinen A; School of Health Sciences, University of Tampere, Tampere, Finland.
  • Andriole GL; Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.
  • Roobol MJ; Department of Urology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Crawford ED; Urologic Oncology, University of Colorado, Denver, Colorado.
  • Nelen V; Provinciaal Instituut voor Hygiene, Antwerp, Belgium.
  • Kwiatkowski M; Department of Urology, Aarau Canton Hospital, Aarau, Switzerland.
  • Zappa M; Unit of Epidemiology, Institute for Cancer Prevention, Florence, Italy.
  • Luján M; Urology Service, Infanta Cristina University Hospital, Complutense University of Madrid, Parla, Madrid, Spain.
  • Villers A; Department of Urology, Regional University Hospital Center, Lille, France.
  • de Carvalho TM; Department of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Feuer EJ; Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland.
  • Tsodikov A; Department of Biostatistics, University of Michigan, Ann Arbor, Michigan.
  • Mariotto AB; Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland.
  • Heijnsdijk EAM; Department of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Etzioni R; Division of Public Health Sciences, Fred Hutchinson Cancer Research Institute, Seattle, Washington.
Cancer ; 124(6): 1197-1206, 2018 03 15.
Article en En | MEDLINE | ID: mdl-29211316
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Ensayos Clínicos Controlados Aleatorios como Asunto / Tamizaje Masivo / Antígeno Prostático Específico / Detección Precoz del Cáncer Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Incidence_studies / Prognostic_studies / Screening_studies Límite: Aged / Humans / Male / Middle aged País/Región como asunto: America do norte / Europa Idioma: En Revista: Cancer Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Ensayos Clínicos Controlados Aleatorios como Asunto / Tamizaje Masivo / Antígeno Prostático Específico / Detección Precoz del Cáncer Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Incidence_studies / Prognostic_studies / Screening_studies Límite: Aged / Humans / Male / Middle aged País/Región como asunto: America do norte / Europa Idioma: En Revista: Cancer Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos